Studying Apalutamide With ADT in High-Risk Localized Prostate Cancer

1 year ago 42

Vitaly Margulis, MD, discusses the Apa-RP study of adjuvant treatment consisting of apalutamide and androgen deprivation therapy in patients with high-risk localized prostate cancer.

1. Homepage
2. Cancer
3. Studying Apalutamide With ADT in High-Risk Localized Prostate Cancer